Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99mTc-Annexin V-128 SPECT for Endocarditis and Atrial Thrombus
NCT02459613Phase 2Terminated
- Sponsor
- Inserm
- Start
- Feb 2016
- Primary completion
- May 2017
- Countries
- 1
01
Overview
A Phase 2 trial of technetium-tc99m-labeled annexin a5 in infective endocarditis (IE), Atrial thrombus, sponsored by Inserm. Started Feb 2016; status: terminated.
02
Drugs
technetium-tc99m-labeled annexin a5
03
Conditions
infective endocarditis (IE)Atrial thrombus
Beyond the preview
Go deeper on NCT02459613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02459613.